Kurs
+5,02%
Kurs
+5,02%
Open
638,00
High
670,00
Low
632,00
Close
670,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
1,00 MNOK
Likviditet
1,00 MNOK
Rel. mcap
0,17%
Antal aktier
1 529
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2027-04-29 | N/A | Årsstämma |
| 2027-02-11 | 07:30 | Bokslutskommuniké 2026 |
| 2026-11-05 | 07:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-20 | 07:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-07 | - | Kvartalsrapport 2026-Q1 |
| 2026-04-24 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2026-04-23 | - | Årsstämma |
| 2026-02-12 | - | Bokslutskommuniké 2025 |
| 2025-11-25 | - | Extra Bolagsstämma 2025 |
| 2025-11-06 | - | Kvartalsrapport 2025-Q3 |
| 2025-08-20 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-29 | - | Årsstämma |
| 2025-04-24 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2025-04-01 | - | Split ZLNA 10:1 |
| 2025-01-31 | - | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-25 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2024-04-24 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-08 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-22 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2021-04-21 | - | Årsstämma |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-11-11 | - | Extra Bolagsstämma 2020 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-16 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2020-04-15 | - | Årsstämma |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2021-03-08 17:44:39
Oslo, 8 March 2021, the Board of Directors of Ultimovacs ASA (the "Company") has
resolved to increase the Company's share capital by NOK 2,975 through the
issuance of 29,750 new shares, each with a par value of NOK 0.10. The resolution
is based on an authorisation to increase the share capital granted by the
Company's general meeting on 23 April 2020.
The new shares are issued to employees of the Company in connection with the
Company's employee incentive program. The new shares are issued at a
subscription price of NOK 31.25.
Following registration of the share capital increase with the Norwegian Register
of Business Enterprises, the Company will have a share capital of NOK
3,200,326.1, divided into 32,003,261 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632